We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Blockchain Coinvestors Acquisition Corporation I | NASDAQ:BCSAU | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.15 | 11.05 | 12.67 | 4 | 01:00:00 |
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Cayman Islands
|
98-1607883
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Units, each consisting of one Class A ordinary share, par value $0.0001 per share,
and one-half of
one Redeemable Warrant
|
BCSAU
|
The Nasdaq Stock Market LLC
|
||
Class A ordinary shares, par value $0.0001 per share, included as part of the Units
|
BCSA
|
The Nasdaq Stock Market LLC
|
||
Redeemable Warrants included as part of the Units
|
BCSAW
|
The Nasdaq Stock Market LLC
|
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated
filer
|
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
|
|
Page
|
|
|
Part I. Financial Information
|
|
|||
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
4
|
|
|
|
|
5
|
|
|
|
|
15
|
|
|
|
|
18
|
|
|
|
|
19
|
|
|
Part II. Other Information
|
|
|||
|
|
20
|
|
|
|
|
20
|
|
|
|
|
20
|
|
|
|
|
20
|
|
|
|
|
20
|
|
|
|
|
21
|
|
|
|
|
21
|
|
|
|
|
23
|
|
September 30,
2021 |
||||
(unaudited)
|
||||
Assets:
|
||||
Cash
|
$ | 25,000 | ||
Deferred offering costs
|
675,812 | |||
|
|
|||
Total assets
|
$ | 700,812 | ||
|
|
|||
Liabilities and Shareholder’s Equity
|
||||
Accrued offering costs
|
$ | 569,945 | ||
Promissory Note – Related Party
|
110,867 | |||
|
|
|||
Total current liabilities
|
680,812 | |||
|
|
|||
Commitments and Contingencies (Note 6)
|
||||
Shareholder’s Equity:
|
||||
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
|
— | |||
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued and outstanding
|
— | |||
Class B ordinary shares, $0.00009 par value, 50,000,000 shares authorized, 10,005,000 shares issued and outstanding
(1)
|
900 | |||
Additional paid-in capital
|
24,100 | |||
Accumulated deficit
|
(5,000 | ) | ||
|
|
|||
Total shareholder’s equity
|
20,000 | |||
|
|
|||
Total Liabilities and Shareholder’s Equity
|
$ | 700,812 | ||
|
|
(1) |
Includes up to 1,125,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. Effective November 9, 2021, the Company effected a stock split and a stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.
The accompanying financial statements have been adjusted to reflect the stock split and stock dividend. See Notes 5 and 9.
|
For the three
months ended September 30, 2021 |
For the period
from June 11, 2021 (inception) through September 30, 2021 |
|||||||
General and administrative expenses
|
$ | 5,000 | $ | 5,000 | ||||
|
|
|
|
|||||
Net loss
|
$ | (5,000 | ) | $ | (5,000 | ) | ||
|
|
|
|
|||||
Weighted average shares outstanding, basic and diluted
(1)
|
8,700,000 | 8,700,000 | ||||||
|
|
|
|
|||||
Basic and diluted net loss per share
|
$ | (0.00 | ) | $ | (0.00 | ) | ||
|
|
|
|
(1) |
Includes up to 1,125,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. Effective November 9, 2021, the Company effected a stock split and a stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.
The accompanying financial statements have been adjusted to reflect the stock split and stock dividend. See Notes 5 and 9.
|
|
|
Class B Ordinary Shares
|
|
|
Additional
Paid-in
Capital
|
|
|
Accumulated
Deficit
|
|
|
Total
Shareholder’s
Equity
|
|
||||||||
|
|
Shares
|
|
|
Amount
|
|
||||||||||||||
Balance—June 11, 2021 (inception)
|
— | $ | — | $ | — | $ | — | $ | — | |||||||||||
Issuance of Class B ordinary shares to Sponsor
(1)
|
10,005,000 | 900 | 24,100 |
|
—
|
|
25,000 | |||||||||||||
Net loss
|
— | — | — | (5,000 | ) | (5,000 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of June 30, 2021 (unaudited)
|
10,005,000 | $ | 900 | $ | 24,100 | $ | (5,000 | ) | $ | 20,000 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net loss
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of September 30, 2021 (unaudited)
|
|
|
10,005,000
|
|
|
$
|
900
|
|
|
$
|
24,100
|
|
|
$
|
(5,000
|
)
|
|
$
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes up to 1,125,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. Effective November 9, 2021, the Company effected a stock split and a stock dividend with respect to Class B ordinary shares, resulting in 10,005,000 Class B ordinary shares being issued and outstanding, 1,305,000 of which are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters.
The accompanying financial statements have been adjusted to reflect the stock split and stock dividend. See Notes 5 and 9.
|
Cash Flows from Operating Activities:
|
||||
Net loss
|
$ | (5,000 | ) | |
Changes in operating assets and liabilities
|
||||
Accrued expenses
|
5,000 | |||
|
|
|||
Net cash used in operating activities
|
— | |||
|
|
|||
Cash Flows from Financing Activities:
|
||||
Proceeds from sale of Class B ordinary shares to initial shareholders
|
25,000 | |||
|
|
|||
Net cash provided by financing activities
|
25,000 | |||
|
|
|||
Net change in cash
|
25,000 | |||
Cash—beginning of the period
|
— | |||
|
|
|||
Cash—end of the period
|
$ | 25,000 | ||
|
|
|||
Supplemental disclosure of
non-cash
investing and financing activities:
|
||||
Deferred offering costs included in accrued expenses
|
$ | 564,945 | ||
|
|
|||
Deferred offering costs paid by Sponsor under the promissory note
|
$ | 110,867 | ||
|
|
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
|
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
• |
in whole and not in part;
|
• |
at a price of $0.01 per warrant;
|
• |
upon a minimum of 30 days’ prior written notice of redemption; and
|
• |
if, and only if, the Redemption Reference Price equals or exceeds $18.00 per share (as adjusted).
|
32.1** | Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350. | |
32.2** | Certification of Principal Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350. | |
101.INS | Inline XBRL Instance Document—the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document. | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |
104 | Cover page formatted as Inline XBRL and contained in Exhibit 101. |
* |
Filed herewith
|
** |
Furnished herewith
|
Blockchain Coinvestors Acquisition Corp. I
|
||||||
Date: December 27, 2021 | By: |
/s/ Lou Kerner
|
||||
Name: | Lou Kerner | |||||
Title: | Chief Executive Officer | |||||
(Principal Executive Officer) | ||||||
Date: December 27, 2021 | By: |
/s/ Mitchell Mechigian
|
||||
Name: | Mitchell Mechigian | |||||
Title: | Chief Financial Officer | |||||
(Principal Financial Officer) |
1 Year Blockchain Coinvestors A... Chart |
1 Month Blockchain Coinvestors A... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions